[ad_1] PALO ALTO, Calif.–(BUSINESS WIRE)– Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that initial results from the PEGASUS trial suggest liquid biopsy may be used…
Tag: BioSpace
Numab Therapeutics Announces First Patient Dosed in Phase 1 Multiple Ascending Dose (MAD) Study of NM26 for Moderate to Severe Atopic Dermatitis | BioSpace
[ad_1] HORGEN, Switzerland–(BUSINESS WIRE)– Numab Therapeutics AG (Numab), a clinical stage biotechnology company advancing a proprietary pipeline of immunology and oncology therapeutics, announced today that the first patient has been…
GeNeuro and Verily Collaborate to Advance Long-COVID Research | BioSpace
[ad_1] Partnership to combine GeNeuro’s expertise in HERVs with Verily’s Immune Profiler and Workbench platforms to investigate biomarkers related to HERV-W GENEVA, Switzerland–(BUSINESS WIRE)– GeNeuro (Euronext Paris: CH0308403085 – GNRO),…
STAAR Surgical Celebrates 30th Anniversary of Implantable Collamer® Lens (ICL) | BioSpace
[ad_1] LAKE FOREST, Calif.–(BUSINESS WIRE)– STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, is celebrating the 30th anniversary of its proprietary…
EMD Serono to Present Latest Research from Oncology Portfolio at ESMO 2023 | BioSpace
[ad_1] ROCKLAND, Mass.–(BUSINESS WIRE)– EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany in the US and Canada, today announced that 28 abstracts featuring the latest research on the…
Everest Medicines’ Licensing Partner Pfizer Announces U.S. FDA Approves Etrasimod for Adults with Moderately to Severely Active Ulcerative Colitis | BioSpace
[ad_1] SHANGHAI, Oct. 15, 2023 /PRNewswire/ — Everest Medicines (HKEX 1952.HK) announced today that its licensing partner, Pfizer Inc. (NYSE: PFE) has received approval from the U.S. Food and Drug…
Poxel Announces its Participation at Upcoming October 2023 Investor Conferences | BioSpace
[ad_1] LYON, France–(BUSINESS WIRE)– Regulatory News: POXEL SA (Euronext: POXEL – FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis…
KHB Becomes First Chinese Company to Obtain EU Class D IVDR Certification for Its Rapid Test HIV Colloidal Gold Diagnostic Kit | BioSpace
[ad_1] SHANGHAI, Oct. 11, 2023 /PRNewswire/ — Shanghai Kehua Bio-engineering Co., Ltd (“KHB” or “the Company”, Stock code: 002022.SZ), China’s leading In Vitro Diagnostic (IVD) company has achieved a significant…
Opinion: Big Tech’s Move into Biopharma Could Disrupt the Industry | BioSpace
[ad_1] Pictured: Abstract 3D grid/iStock, carloscastilla Artificial intelligence is a rapidly evolving field that has experienced exponential growth over the past decade. During that time, the accumulation of vast amounts…